Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: User-agent: AhrefsSiteAudit Allow: / User-agent: AhrefsBot Allow: / sitemap: https://www.dupixenthcp.com/sitemap.xml sitemap: https://www.dupixenthcp.com/atopicdermatitis/sitemap.xml sitemap: https://www.dupixenthcp.com/asthma/sitemap.xml sitemap: https://www.dupixenthcp.com/crswnp/sitemap.xml sitemap: https://www.dupixenthcp.com/eoe/sitemap.xml sitemap: |
Title | DUPIXENT® (dupilumab) HCP |
Description | Only DUPIXENT specifically targets IL-4 and IL-13 signaling and is approved for 5 DUPIXENT® (dupilumab) is a dual inhibitor of IL-4 and IL-13 signaling and is approved for 5 indications. Serious adverse reactions may occur. Please see Important Safety Information and full Prescribing Information on |
Keywords | N/A |
WebSite | dupixenthcp.com |
Host IP | 40.79.44.181 |
Location | United States |
Site | Rank |
US$65,835,063
Last updated: 2023-05-02 15:27:13
dupixenthcp.com has Semrush global rank of 160,770. dupixenthcp.com has an estimated worth of US$ 65,835,063, based on its estimated Ads revenue. dupixenthcp.com receives approximately 7,596,354 unique visitors each day. Its web server is located in United States, with IP address 40.79.44.181. According to SiteAdvisor, dupixenthcp.com is safe to visit. |
Purchase/Sale Value | US$65,835,063 |
Daily Ads Revenue | US$60,771 |
Monthly Ads Revenue | US$1,823,125 |
Yearly Ads Revenue | US$21,877,498 |
Daily Unique Visitors | 506,424 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
dupixenthcp.com. | A | 900 | IP: 40.79.44.181 |
dupixenthcp.com. | NS | 900 | NS Record: ns4.sanofi-synthelabo.com. |
dupixenthcp.com. | NS | 900 | NS Record: ns1.sanofi-synthelabo.com. |
dupixenthcp.com. | NS | 900 | NS Record: ns2.sanofi-synthelabo.com. |
dupixenthcp.com. | NS | 900 | NS Record: ns3.sanofi-synthelabo.com. |
dupixenthcp.com. | TXT | 900 | TXT Record: facebook-domain-verification=odlzz8enn9kor2ac0tiz50u7l36j5e |
× Rate your conversation ? ? ? ? × Thanks for the feedback! For U.S. Healthcare Professionals Only Prescribing Information PRESCRIBING INFORMATION Prescribing Information - English Prescribing Information - Spanish PRE-FILLED SYRINGE INSTRUCTIONS FOR USE 100 mg Dose - English 100 mg Dose - Spanish 200 mg Dose - English 200 mg Dose - Spanish 300 mg Dose - English 300 mg Dose - Spanish PRE-FILLED PEN INSTRUCTIONS FOR USE 200 mg Dose - English 200 mg Dose - Spanish 300 mg Dose - English 300 mg Dose - Spanish Visit Patient Site Contact a Rep Select Condition Moderate-to-Severe Atopic Dermatitis Moderate-to-Severe Asthma Chronic Rhinosinusitis with Nasal Polyposis Eosinophilic Esophagitis Prurigo Nodularis PATIENT SUPPORT PROGRAM DUPIXENT MyWay® Program Overview Patient Enrollment Insurance Coverage Support Copay and Patient Access Support Nursing Support Visit Patient Site Only DUPIXENT specifically targets IL-4 and IL-13 signaling and is approved for 5 indications. 1,a To continue to a |
HTTP/1.1 301 Moved Permanently Content-Length: 151 Content-Type: text/html; charset=UTF-8 Location: https://www.dupixenthcp.com/ Server: Microsoft-IIS/8.5 Access-Control-Allow-Origin: * Access-Control-Allow-Headers: Origin, X-Requested-With, Content-Type, Accept Access-Control-Allow-Methods: GET, POST, PUT, DELETE, OPTIONS X-Frame-Options: SAMEORIGIN Date: Mon, 25 Oct 2021 01:16:42 GMT HTTP/2 200 cache-control: private content-length: 90721 content-type: text/html; charset=utf-8 server: Microsoft-IIS/8.5 x-aspnetmvc-version: 5.2 x-aspnet-version: 4.0.30319 request-context: appId=cid-v1:352d0284-ac30-451f-a41e-2b6fd36930be access-control-allow-origin: * access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept access-control-allow-methods: GET, POST, PUT, DELETE, OPTIONS x-frame-options: SAMEORIGIN date: Mon, 25 Oct 2021 01:16:43 GMT set-cookie: ASP.NET_SessionId=zrt1ov3dcz3ponm3v3k14s5d; path=/; secure; HttpOnly; SameSite=Lax set-cookie: SC_ANALYTICS_GLOBAL_COOKIE=373e8c616c234d53ad56c03241554a98|False; expires=Sat, 25-Oct-2031 01:16:42 GMT; path=/; secure; HttpOnly |
Domain Name: DUPIXENTHCP.COM Registry Domain ID: 2065906766_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2020-10-09T05:18:59Z Creation Date: 2016-10-13T15:08:29Z Registry Expiry Date: 2022-10-13T15:08:29Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.SANOFI-SYNTHELABO.COM Name Server: NS2.SANOFI-SYNTHELABO.COM Name Server: NS3.SANOFI-SYNTHELABO.COM Name Server: NS4.SANOFI-SYNTHELABO.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T06:20:26Z <<< |